ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PBI vs DBD // EV/EBITDA & P/E VALUATION

Pitney Bowes Inc. (NYSE) VS. Diebold Nixdorf Incorporated (NYSE) • 15-METRIC TALLY: PBI 5 — DBD 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PBI VS. DBD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PBI DBD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 25.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 11.50% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 10.6x — TIE /valuation <GO>
Free Cash Flow Yield 14.05% 15.14% -1.09 DBD /fcf-yield <GO>
Operating Margin — 6.40% — TIE /operating-margins <GO>
Net Profit Margin 7.60% 2.50% +5.10 PBI /net-margins <GO>
Revenue Growth (YoY) -6.60% 1.50% -8.10 DBD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 2.26% 0.00% +2.26 PBI /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.79 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 DBD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.2 27.7 +11.54 PBI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 14.5x 19.5x -5.00 PBI /forward-pe <GO>
Enterprise Scale & Market Cap $2.26B $1.99B $270.2M PBI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PBI REV DBD REV PBI GROSS % DBD GROSS % PBI FCF DBD FCF
FY 2025 $1.89B $3.81B — 25.3% $317.0M $300.7M
FY 2024 $2.03B $3.75B 52.4% 24.5% $156.8M $149.2M
FY 2023 $2.08B — — — $80.1M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PBI // BETA —
DBD // BETA —